LEADER 01646nam  2200541   450 
001 9910823679503321
005 20230807212910.0
010   $a93-86150-11-5
035   $a(CKB)3710000000847052
035   $a(EBL)4659910
035   $a(SSID)ssj0001656285
035   $a(PQKBManifestationID)16437112
035   $a(PQKBTitleCode)TC0001656285
035   $a(PQKBWorkID)14984606
035   $a(PQKB)11014459
035   $a(MiAaPQ)EBC4659910
035   $a(Au-PeEL)EBL4659910
035   $a(CaPaEBR)ebr11253359
035   $a(OCoLC)958384887
035   $a(EXLCZ)993710000000847052
100   $a20160915h20152015  uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aCardiac drugs /$feditors, Kanu Chatterjee, Eric J. Topol
205   $aSecond edition.
210  1$aNew Delhi, [India] :$cJaypee, The Health Sciences Publisher,$d2015.
210  4$dİ2015
215   $a1 online resource (551 p.)
300   $aDescription based upon print version of record.
311   $a93-5152-851-0 
320   $aIncludes bibliographical references at the end of each chapters and index.
606   $aCardiovascular agents$xPhysiological effect
606   $aHeart$xDiseases$xChemotherapy
615  0$aCardiovascular agents$xPhysiological effect.
615  0$aHeart$xDiseases$xChemotherapy.
676   $a615.71
702   $aChatterjee$b Kanu
702   $aTopol$b  Eric J.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910823679503321
996   $aCardiac drugs$94013271
997   $aUNINA